Clever Leaves : Investor Presentation

August 2023

Who We Are

Our operations in Colombia produce cannabinoid active pharmaceutical ingredients (API) and finished products in the form of flowers and extracts

We provide value by facilitating an asset-light go-to-market strategy for our partners

We facilitate downstream distribution and branding for select markets, with both white-label and CLVR-owned brands

Clever Leaves aims to disrupt the traditional cannabis production industry by leveraging environmentally-sustainable,industrial scale and low-cost

production methods wrapped in the world's most stringent

pharmaceutical quality certifications

1

Investment Highlights

1 Low-cost cultivation leader in Colombia

2	Multinational operator decoupling production and
commercialization - we do both where it makes sense
3	Pharmaceutical-grade production authorized for export, with multi-
year product cycles now reaching commercial delivery phase
4	Seasoned global leadership team with operational & regulatory
expertise in key geographies
5	Focused on driving scale and cash flow generation leveraging
attractive unit economics

2

Clever Leaves' Goal is to Become a Hub in the

Global Cannabinoid Supply Chain

United Kingdom

Germany

Portugal

Colombia

Brazil

Legend

Focus Markets

Cultivation/Production

New Q2'23 Destinations

Czech Republic

Switzerland

Israel

Australia

3

Focused on Key International Markets

The combination of commercial efforts and regulatory viability makes the following markets key regions of focus

Near-Term Focus (2023)

Australia	Brazil	Colombia	Germany	Israel	United
Kingdom
		(Domestic/Rec Market)

Long-Term Targets

Ecuador

Italy

Mexico

Panama

Poland

4